| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |